Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Agendia N.V.
Headquarters: Amsterdam, Netherlands
Website: http://www.agendia.com
Year Founded: 2003
Status: Private
BioCentury | May 11, 2022
Management Tracks
Shea replacing Kim as CEO of Inovio
Plus new chief commercial officer at DNA Script, and updates from Boston Pharma, Quantum SI, Beta, Longeveron and more
BioCentury | Mar 17, 2022
Management Tracks
Denali co-founder, COO Schuth to take on CFO role
Plus Immunic promotes Whaley to CFO and updates from Mablink, Agendia, SNIPR and more
BioCentury | Jan 21, 2022
Deals
Illumina deal takes Agendia’s tests directly to hospitals
Partners to develop new tests for breast cancer as part of push to decentralize NGS testing
BioCentury | Jan 12, 2022
Deals
Jan. 11 Quick Takes: Roche cash infusion brings Freenome’s overall haul to $1.1B
Plus: NCI licenses for Neogene, Sana and updates from Allogene-Antion, Illumina bluebird, ONK, Gameto
BioCentury | Aug 1, 2020
Management Tracks
Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more
BioCentury | Aug 17, 2017
Translation in Brief
Stopping the invasion
How targeting the IRF3 pathway could prevent GBM recurrence
Items per page:
1 - 10 of 18